Michael Ackermann, PhD
Oyster Point Pharmaceuticals
Michael Ackermann is Chairman of Oyster Point Pharmaceuticals, Inc., Chairman of Tarsus Pharmaceuticals, Inc. and acting CEO of medical device company Presidio Medical, Inc. Michael is also teaching faculty at Stanford University’s Biodesign graduate program. Prior, Michael served as Vice President, Neurostimulation for Allergan, plc after serving as CEO of Oculeve, Inc., which was acquired by Allergan in August 2015. He received a bachelor’s degree in biomedical engineering from Vanderbilt University, M.S. and Ph.D. degrees in biomedical engineering from Case Western Reserve University is a graduate of the Stanford University Biodesign Fellowship, and Vision Research Fellowship at Stanford.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.